These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 3680605)
21. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. Khan A; Jaffe JH; Nelson WH; Morrison B J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961 [TBL] [Abstract][Full Text] [Related]
22. [A study of neuroleptic malignant syndrome in the presenium and senium]. Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353 [TBL] [Abstract][Full Text] [Related]
23. Porcine stress syndrome: an animal model for the neuroleptic malignant syndrome? Keck PE; Seeler DC; Pope HG; McElroy SL Biol Psychiatry; 1990 Jul; 28(1):58-62. PubMed ID: 2115811 [TBL] [Abstract][Full Text] [Related]
24. [Pharmacological treatment of delusional depression]. Amore M; Giordani L; Giorgetti G; Zazzeri N Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200 [TBL] [Abstract][Full Text] [Related]
25. Neuroleptic malignant syndrome in the intensive care unit. Sing RF; Branas CC; Marino PL J Am Osteopath Assoc; 1993 May; 93(5):615-8. PubMed ID: 8314724 [TBL] [Abstract][Full Text] [Related]
28. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. Ozen ME; Yumru M; Savas HA; Cansel N; Herken H World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349 [TBL] [Abstract][Full Text] [Related]
29. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report. Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107 [TBL] [Abstract][Full Text] [Related]
30. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient. Bottlender R; Jäger M; Hofschuster E; Dobmeier P; Möller HJ Pharmacopsychiatry; 2002 May; 35(3):119-21. PubMed ID: 12107858 [TBL] [Abstract][Full Text] [Related]
32. [Neuroleptic malignant syndrome: presentation of a case treated with sulpiride]. Brescia A; Zocchi M Riv Neurol; 1991; 61(5):169-71. PubMed ID: 1808673 [TBL] [Abstract][Full Text] [Related]
33. Neuroleptic malignant syndrome: a complication of neuroleptics and cocaine abuse. Akpaffiong MJ; Ruiz P Psychiatr Q; 1991; 62(4):299-309. PubMed ID: 1687338 [TBL] [Abstract][Full Text] [Related]
34. Neuroleptic malignant syndrome related to use of clozapine. Trayer JS; Fidler DC J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834 [TBL] [Abstract][Full Text] [Related]
35. Neuroleptic malignant syndrome in Mexico. Montoya A; Ocampo M; Torres-Ruiz A Can J Clin Pharmacol; 2003; 10(3):111-3. PubMed ID: 14506509 [TBL] [Abstract][Full Text] [Related]
36. Management of neuroleptic malignant syndrome--a series of eight cases. Kurien T; Rajeev KK; Abraham OC; Archana S; Cherian AM J Assoc Physicians India; 1993 Feb; 41(2):91-3. PubMed ID: 8101521 [TBL] [Abstract][Full Text] [Related]
39. Neuroleptic malignant syndrome in 12 of 9,792 Chinese inpatients exposed to neuroleptics: a prospective study. Deng MZ; Chen GQ; Phillips MR Am J Psychiatry; 1990 Sep; 147(9):1149-55. PubMed ID: 1974744 [TBL] [Abstract][Full Text] [Related]
40. Movement disorders with neuroleptic drug treatment. Tarsy D Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]